Brought to you by 
Series A raises $15mm for respiratory start-up Elevation; completes round at $32mm
27 Sep 2011
Executive Summary
Pulmonary drug delivery start-up Elevation Pharmaceuticals has raised $15mm in a tranched Series A financing from Canaan Partners, TPG Growth, Care Capital, and Mesa Verde Venture Partners. Representatives from Canaan, TPG, and Care Capital joined the company's board.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Pulmonary
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series A raises $15mm for respiratory start-up Elevation; completes round at $32mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice